Edouard Caram

Sr Director Global Partnering Neurosciences & Rare Diseases

2022 - Current

Business Angel

2020

Board Member

2021

Open Stent Solution (OSS) develops the first longitudinally expandable valved stent, paving the way for the new open stent concept for the treatment of heart valve disease.

Board Member

2021 - 2022

Blog founder

2020 - 2022

In VCLife topics dealing with early sciences, funding, entrepreneurs, Big Pharmas, M&A, patients care will be openly debate. There will be an important footprint on Therapeutics but Med Tech, Diagnostic and the revolution of Digital Health will also feed the posts. Discussion and feed back are always welcome thus do not hesitate to comment or email me.

FONDATEUR ET DIRIGEANT

2015 - 2022

CLOSINVIT est une plateforme unique d'invitations pour des spectacles vivants. Cinéma, théâtre, spectacles humoristiques, nouvelles comédies, nouvelles production à découvrir. CLOSINVIT: INVITEZ-VOUS ! www.closinvit.com

Fondateur et dirigeant

2011 - 2022

Billetterie en ligne et promotion de spectacles vivants avec près de 60'000 membres. Rejoignez Closevent sur: http://www.closevent.com/mon_compte-10.html

Investment Analyst Life Science

2007 - 2010

Evaluation of early stage/ spin off investments in Life Science (Biopharma and device companies). Sourcing, diligence of > 400 opportunities and completion of 2 US deals.

Manager Marketing & Corporate Development Europe

2006 - 2007

In charge of the Marketing strategy and activities of the company portfolio in Europe (Monoclonal Antibodies in Inflammation, Solid tumor, multiple myeloma)

Manager Business Development (Licence & acquisition)

2002 - 2006

Co-leading EU licensing/ acquisition projects in METABOLISM (diabetes/ obesity) and VIROLOGY (HIV, HBV, HCV, vaccines).